TY - JOUR
T1 - Soft tissue sarcoma, version 2.2018
T2 - Clinical practice guidelines in oncology
AU - Mehren, Margaret Von
AU - Randall, R. Lor
AU - Benjamin, Robert S.
AU - Boles, Sarah
AU - Bui, Marilyn M.
AU - Ganjoo, Kristen N.
AU - George, Suzanne
AU - Gonzalez, Ricardo J.
AU - Heslin, Martin J.
AU - Kane, John M.
AU - Keedy, Vicki
AU - Kim, Edward
AU - Koon, Henry
AU - Mayerson, Joel
AU - McCarter, Martin
AU - McGarry, Sean V.
AU - Meyer, Christian
AU - Morris, Zachary S.
AU - O'Donnell, Richard J.
AU - Pappo, Alberto S.
AU - Paz, I. Benjamin
AU - Petersen, Ivy A.
AU - Pfeifer, John D.
AU - Riedel, Richard F.
AU - Ruo, Bernice
AU - Schuetze, Scott
AU - Tap, William D.
AU - Wayne, Jeffrey D.
AU - Bergman, Mary Anne
AU - Scavone, Jillian L.
N1 - Publisher Copyright:
© JNCCN-Journal of the National Comprehensive Cancer Network.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
AB - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
UR - http://www.scopus.com/inward/record.url?scp=85046897802&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2018.0025
DO - 10.6004/jnccn.2018.0025
M3 - Review article
C2 - 29752328
AN - SCOPUS:85046897802
SN - 1540-1405
VL - 16
SP - 536
EP - 563
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 5
ER -